Enrollment completed across 18 clinical sites with 40+ investigators in the US, Canada, and New Zealand If the GPX ...

Embolic protection devices are essential instruments during such operations since they play a crucial role in reducing these hazards. The market for embolic protection devices is growing in both ...

The global TAVR embolic protection market is experiencing steady growth, with revenue estimated to increase from approximately $124 million in 2023 to around $403 million by 2032. This growth, driven ...

Fluidx Medical Technology, Inc. announced the completion of patient enrollment in the investigational device exemption (IDE) piv ...

SALT LAKE CITY, UTAH, UNITED STATES , May 21, 2024 /EINPresswire.com/ -- Fluidx Medical Technology, Inc. announced today that the FDA has granted Investigational ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...

(MENAFN- GlobeNewsWire - Nasdaq) Key states, including California and Texas, lead in demand due to advanced healthcare systems and aging populations Dublin, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The ...